Biology of TNFα and IL-10, and their imbalance in heart failure (original) (raw)

• Kaur K, Sharma AK, Singal PK (2006) Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291:H106–H113. doi:10.1152/ajpheart.01327.2005
  PubMed CAS Google Scholar
• Dhingra S, Sharma AK, Singla DK, Singal PK (2007) p38 and ERK 1/2 MAPkinases mediate interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 293:H3524–H3531. doi:10.1152/ajpheart.00919.2007
  PubMed CAS Google Scholar
• Kaur K, Sharma AK, Dhingra S, Singal PK (2006) Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol 41:1023–1030. doi:10.1016/j.yjmcc.2006.08.005
  PubMed CAS Google Scholar
• Pulkki KJ (1997) Cytokines and cardiomyocyte death. Ann Med 29:339–343. doi:10.3109/07853899708999358
  PubMed CAS Google Scholar
• Yao YY, Yin H, Shen B, Chao L, Chao J (2007) Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. J Card Fail 13:588–596. doi:10.1016/j.cardfail.2007.04.009
  PubMed CAS Google Scholar
• Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 105:897–904. doi:10.1378/chest.105.3.897
  PubMed CAS Google Scholar
• Seta Y, Shan K, Bozkurt B, Oral H, Mann DL (1996) Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 2:243–249. doi:10.1016/S1071-9164(96)80047-9
  PubMed CAS Google Scholar
• Langer SE, Scheer JF (1995) Solved—the riddle of illness. Keats Pub, USA
  Google Scholar
• Deidier A (1725) Dissertation Medecinal et Chirurgical sur les Tumeurs, Paris
• Kolmel K, Pfahlberg A, Mastrangelo G et al (1999) Infections and melanoma risk: results of a multicentre EORTC case-study. Melanoma Res 9:511–519
  PubMed CAS Google Scholar
• Busch W (1868) Aus der Sitzung der medicinischen Section vom 13 November 1867. Berl Klin Wochenschr 5:137
  Google Scholar
• Bruns P (1888) Die Heilwirkung des Erysipelas auf Geschwülste. Beitr Klin Chir 3:443
  Google Scholar
• Lassar O (1891) Zur Erysipelimpfung. Dtsch Med Wochenschr 17:889
  Article Google Scholar
• Coley WB (1893) The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 105:487–511. doi:10.1097/00000441-189305000-00001
  Google Scholar
• Shear HJ, Marks ES (1962) Measuring self-confining behaviour patterns. J Clin Psychol 18:26–28. doi:10.1002/1097-4679(196201)18:1<26::AID-JCLP2270180107>3.0.CO;2-S
  PubMed CAS Google Scholar
• Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666–3670. doi:10.1073/pnas.72.9.3666
  PubMed CAS Google Scholar
• Aggarwal BB, Henzel WJ, Moffat B, Kohr WJ, Harkins RN (1985) Human tumor necrosis factor: production, purification and characterization. J Biol Chem 260:2345–2354
  PubMed CAS Google Scholar
• Matthews N (1978) Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer 38:310–315
  PubMed CAS Google Scholar
• Fiers W (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 285:199–221. doi:10.1016/0014-5793(91)80803-B
  PubMed CAS Google Scholar
• Spiegelman BM, Hotamisligil GS (1993) Through thick and thin: wasting, obesity, and TNF alpha. Cell 73:625–627. doi:10.1016/0092-8674(93)90243-J
  PubMed CAS Google Scholar
• Fiers W, Beyaert R, Brouckaert P et al (1987) Tumor necrosis factor: a potential antitumor agent? J Interferon Res 7:627–634
  PubMed CAS Google Scholar
• Loetscher H, Pan YC, Lahm HW et al (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351–359. doi:10.1016/0092-8674(90)90815-V
  PubMed CAS Google Scholar
• Smith CA, Davis T, Anderson D et al (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023. doi:10.1126/science.2160731
  PubMed CAS Google Scholar
• Vandenabeele P, Declercq W, Beyaert R, Fiers W (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5:392–399. doi:10.1016/S0962-8924(00)89088-1
  PubMed CAS Google Scholar
• Grell M, Douni E, Wajant H et al (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793–802. doi:10.1016/0092-8674(95)90192-2
  PubMed CAS Google Scholar
• Grell M, Wajant H, Zimmermann G, Scheurich P (1998) The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci USA 95:570–575. doi:10.1073/pnas.95.2.570
  PubMed CAS Google Scholar
• Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL (1995) Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92:1487–1493
  PubMed CAS Google Scholar
• Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411–452. doi:10.1146/annurev.iy.10.040192.002211
  PubMed CAS Google Scholar
• Beutler B, Cerami A (1988) Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57:505–518. doi:10.1146/annurev.bi.57.070188.002445
  PubMed CAS Google Scholar
• Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501. doi:10.1016/S0092-8674(01)00237-9
  PubMed CAS Google Scholar
• Loetscher H, Gentz R, Zulauf M et al (1991) Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. J Biol Chem 266:18324–18329
  PubMed CAS Google Scholar
• Wajant H, Henkler F, Scheurich P (2001) The TNF-receptor-associated factor family: scaffold molecules for cytokinereceptors, kinases and their regulators. Cell Signal 13:389–400. doi:10.1016/S0898-6568(01)00160-7
  PubMed CAS Google Scholar
• Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845–853. doi:10.1016/0092-8674(93)90464-2
  PubMed CAS Google Scholar
• Hsu H, Xiong J, Goeddel DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81:495–504. doi:10.1016/0092-8674(95)90070-5
  PubMed CAS Google Scholar
• Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513–523. doi:10.1016/0092-8674(95)90072-1
  PubMed CAS Google Scholar
• Duan H, Dixit VM (1997) RAIDD is a new ‘death’ adaptor molecule. Nature 385:86–89. doi:10.1038/385086a0
  PubMed CAS Google Scholar
• Enari M, Talanian RV, Wong WW, Nagata S (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723–726. doi:10.1038/380723a0
  PubMed CAS Google Scholar
• Vanden Berghe W, Plaisance S, Boone E et al (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273:3285–3290. doi:10.1074/jbc.273.6.3285
  PubMed CAS Google Scholar
• Chang DJ, Ringold GM, Heller RA (1992) Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-alpha is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun 188:538–546. doi:10.1016/0006-291X(92)91089-9
  PubMed CAS Google Scholar
• Kapadia S, Dibbs Z, Kurrelmeyer K et al (1998) The role of cytokines in the failing human heart. Cardiol Clin 16:645–656. doi:10.1016/S0733-8651(05)70041-2
  PubMed CAS Google Scholar
• Rauchhaus M, Coats AJ, Anker SD (2000) The endotoxin-lipoprotein hypothesis. Lancet 356:930–933. doi:10.1016/S0140-6736(00)02690-8
  PubMed CAS Google Scholar
• Blick M, Sherwin SA, Rosenblum M, Gutterman J (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47:2986–2989
  PubMed CAS Google Scholar
• Satoh M, Nakamura M, Tamura G et al (1997) Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 29:716–724. doi:10.1016/S0735-1097(96)00567-0
  PubMed CAS Google Scholar
• Torre-Amione G, Kapadia S, Lee J et al (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
  PubMed CAS Google Scholar
• Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B (1992) The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90:693–698. doi:10.1172/JCI115939
  PubMed CAS Google Scholar
• Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL (1995) Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96:1042–1052. doi:10.1172/JCI118090
  PubMed CAS Google Scholar
• Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL (1997) Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 81:187–195
  PubMed CAS Google Scholar
• Yue P, Massie BM, Simpson PC, Long CS (1998) Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am J Physiol 275:H250–H258
  PubMed CAS Google Scholar
• Meldrum DR, Cleveland JC Jr, Cain BS, Meng X, Harken AH (1998) Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfusedmodel of cardiac ischemia-reperfusion injury. Ann Thorac Surg 65:439–443. doi:10.1016/S0003-4975(97)01297-6
  PubMed CAS Google Scholar
• Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206. doi:10.1016/0735-1097(95)00589-7
  PubMed CAS Google Scholar
• Rauchhaus M, Doehner W, Francis DP et al (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102:3060–3067
  PubMed CAS Google Scholar
• Ferrari R (1998) Tumor necrosis factor in CHF: a double facet cytokine. Cardiovasc Res 37:554–559. doi:10.1016/S0008-6363(97)00309-X
  PubMed CAS Google Scholar
• MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S (1997) Circulating interleukin-6 in severe heart failure. Am J Cardiol 79:1128–1131. doi:10.1016/S0002-9149(96)00063-X
  PubMed CAS Google Scholar
• Testa M, Yeh M, Lee P et al (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28:964–971. doi:10.1016/S0735-1097(96)00268-9
  PubMed CAS Google Scholar
• Torre-Amione G, Stetson SJ, Youker KA et al (1999) Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation 100:1189–1193
  PubMed CAS Google Scholar
• Heard SO, Perkins MW, Fink MP (1992) Tumor necrosis factor-alpha causes myocardial depression in guinea pigs. Crit Care Med 20:523–527. doi:10.1097/00003246-199204000-00015
  PubMed CAS Google Scholar
• Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS (1992) Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 90:389–398. doi:10.1172/JCI115873
  PubMed CAS Google Scholar
• Eichenholz PW, Eichacker PQ, Hoffman WD et al (1992) Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 263:H668–H675
  PubMed CAS Google Scholar
• Eichacker PQ, Hoffman WD, Farese A et al (1991) TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol 71:1979–1989
  PubMed CAS Google Scholar
• Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387–389. doi:10.1126/science.1631560
  PubMed CAS Google Scholar
• Murray DR, Freeman GL (1996) Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 78:154–160
  PubMed CAS Google Scholar
• Bozkurt B, Kribbs SB, Clubb FJ Jr et al (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97:1382–1391
  PubMed CAS Google Scholar
• Kubota T, McTiernan CF, Frye CS et al (1997) Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81:627–635
  PubMed CAS Google Scholar
• Nakamura K, Fushimi K, Kouchi H et al (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98:794–799
  PubMed CAS Google Scholar
• Suematsu N, Tsutsui H, Wen J et al (2003) Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107:1418–1423. doi:10.1161/01.CIR.0000055318.09997.1F
  PubMed CAS Google Scholar
• Bianchi P, Kunduzova O, Masini E et al (2005) Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 22:3297–3305. doi:10.1161/CIRCULATIONAHA.104.528133
  Google Scholar
• Chaiswing L, Cole MP, St Clair DK, Ittarat W, Szweda LI, Oberley TD (2004) Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury. Toxicol Pathol 32:536–547. doi:10.1080/01926230490502601
  PubMed CAS Google Scholar
• Vlessis AA, Muller P, Bartos D, Trunkey D (1991) Mechanism of peroxide-induced cellular injury in cultured adult cardiac myocytes. FASEB J 5:2600–2605
  PubMed CAS Google Scholar
• Li YY, Feng YQ, Kadokami T et al (2000) Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 97:12746–12751. doi:10.1073/pnas.97.23.12746
  PubMed CAS Google Scholar
• Shen J, O’Brein D, Yi X (2006) Matrix metalloproteinases-2 contributes to tumor necrosis factor alpha induced apoptosis in cultured rat cardiac myocytes. Biochem Biophys Res Commun 347:1011–1120. doi:10.1016/j.bbrc.2006.07.002
  PubMed CAS Google Scholar
• Krown KA, Page MT, Nguyen C et al (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 15:2854–2865. doi:10.1172/JCI119114
  Google Scholar
• Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27:1281–1292. doi:10.1016/S0022-2828(05)82390-9
  PubMed CAS Google Scholar
• Natanson C, Eichenholz PW, Danner RL et al (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169:823–832. doi:10.1084/jem.169.3.823
  PubMed CAS Google Scholar
• Castagnoli C, Stella M, Berthod C, Magliacani G, Richiardi PM (1993) TNF production and hypertrophic scarring. Cell Immunol 147:51–563. doi:10.1006/cimm.1993.1047
  PubMed CAS Google Scholar
• Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 79:530–536. doi:10.1210/jc.79.2.530
  PubMed CAS Google Scholar
• Gottschall PE, Yu X (1995) Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64:1513–1520
  Article PubMed CAS Google Scholar
• Mann DL, McMurray JJ, Packer M et al (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109:1594–1602. doi:10.1161/01.CIR.0000124490.27666.B2
  PubMed CAS Google Scholar
• Bozkurt B, Torre-Amione G, Warren MS et al (2001) Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 103:1044–1047
  PubMed CAS Google Scholar
• Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P (1998) Randomized investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet 351:1091–1093. doi:10.1016/S0140-6736(97)09338-0
  PubMed CAS Google Scholar
• Mohler KM, Sleath PR, Fitzner JN et al (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218–220. doi:10.1038/370218a0
  PubMed CAS Google Scholar
• Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177:1675–1680. doi:10.1084/jem.177.6.1675
  PubMed CAS Google Scholar
• Parrillo JE, Cunnion RE, Epstein SE et al (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321:1061–1068
  PubMed CAS Google Scholar
• Berthonneche C, Sulpice T, Boucher F et al (2004) New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats. Am J Physiol Heart Circ Physiol 287:H340–H350. doi:10.1152/ajpheart.01210.2003
  PubMed CAS Google Scholar
• Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol (Baltimore, Md.: 1950) 147:3815–3822
  CAS Google Scholar
• Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW et al (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (Baltimore, Md.: 1950) 146:3444–3451
  CAS Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765. doi:10.1146/annurev.immunol.19.1.683
  PubMed CAS Google Scholar
• Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270:9558–9563. doi:10.1074/jbc.270.16.9558
  PubMed CAS Google Scholar
• Levens JM, Gordon J, Gregory CD (2000) Micro-environmental factors in the survival of human B-lymphoma cells. Cell Death Differ 7:59–69. doi:10.1038/sj.cdd.4400636
  PubMed CAS Google Scholar
• Moore KW, Vieira P, Fiorentino DF et al (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248:1230–1234. doi:10.1126/science.2161559
  PubMed CAS Google Scholar
• Howard M, O’Garra A (1992) Biological properties of interleukin 10. Immunol Today 13:198–200. doi:10.1016/0167-5699(92)90153-X
  PubMed CAS Google Scholar
• Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H (2002) The interleukin-10 family of cytokines. Trends Immunol 23:89–96. doi:10.1016/S1471-4906(01)02149-4
  PubMed CAS Google Scholar
• Platzer C, Volk HD, Platzer M (1994) 5′ noncoding sequence of human IL-10 gene obtained by oligo-cassete PCR walking. DNA Seq 4:399–401. doi:10.3109/10425179409010188
  PubMed CAS Google Scholar
• Platzer C, Docke WD, Volk HD, Prosch S (2000) Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 105:31–38. doi:10.1016/S0165-5728(00)00205-8
  PubMed CAS Google Scholar
• Barsig J, Kusters S, Vogt K, Volk HD, Tiegs G, Wendel A (1995) Lipopolysaccharide-induced IL-10 in mice: role of endogenous TNF-alpha. Eur J Immunol 25:2888–2893. doi:10.1002/eji.1830251027
  PubMed CAS Google Scholar
• Meisel C, Vogt K, Platzer C, Randow F, Liebenthal C, Volk HD (1996) Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression. Eur J Immunol 26:1580–1586. doi:10.1002/eji.1830260726
  PubMed CAS Google Scholar
• Ma W, Lim W, Gee K et al (2001) The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J Biol Chem 276:13664–13674
  PubMed CAS Google Scholar
• Walter MR (2002) Strucure of interleukin-10/interleukin-10R1 complex: a paradigm for class 2 cytokine activation. Immunol Res 26:303–308. doi:10.1385/IR:26:1-3:303
  PubMed CAS Google Scholar
• Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA (1995) Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J Immunol (Baltimore, Md.: 1950) 154:3454–3460
  CAS Google Scholar
• Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN (1999) Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 155:1929–1939
  PubMed CAS Google Scholar
• vander Poll T, Marchant A, Buurman WA et al (1995) Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 155:5397–5401
  CAS Google Scholar
• Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL (1995) Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol (Baltimore, Md.: 1950) 155:2222–2229
  CAS Google Scholar
• Lang R, Rutschman RL, Greaves DR, Murray PJ (2002) Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J Immunol (Baltimore, Md.: 1950) 168:3402–3411
  CAS Google Scholar
• Hess PJ, Seeger JM, Huber TS et al (1997) Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J Vasc Surg 26:113–118. doi:10.1016/S0741-5214(97)70154-X
  PubMed CAS Google Scholar
• Engles RE, Huber TS, Zander DS et al (1997) Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J Surg Res 69:425–428. doi:10.1006/jsre.1997.5109
  PubMed CAS Google Scholar
• Byrne A, Reen DJ (2002) Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol (Baltimore, Md.: 1950) 168:1968–1977
  CAS Google Scholar
• Levy Y, Brouet JC (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 93:424–428. doi:10.1172/JCI116977
  PubMed CAS Google Scholar
• Finbloom DS, Winestock KD (1995) IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol (Baltimore, Md.: 1950) 155:1079–1090
  CAS Google Scholar
• Clarke CJ, Hales A, Hunt A, Foxwell BM (1998) IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol 28:1719–1726. doi:10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q
  PubMed CAS Google Scholar
• Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr (1999) Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 274:31868–31874. doi:10.1074/jbc.274.45.31868
  PubMed CAS Google Scholar
• Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 135:64–73. doi:10.1111/j.1365-2249.2004.02342.x
  PubMed CAS Google Scholar
• Cassatella MA, Gasperini S, Bovolenta C et al (1999) Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94:2880–2889
  PubMed CAS Google Scholar
• Ito S, Ansari P, Sakatsume M et al (1999) Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93:1456–1463
  PubMed CAS Google Scholar
• Donnelly RP, Dickensheets H, Finbloom DS (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19:563–573. doi:10.1089/107999099313695
  PubMed CAS Google Scholar
• Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A, Bazzoni F (2002) Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol (Baltimore, Md.: 1950) 168:6404–6411
  CAS Google Scholar
• Lee TS, Chau LY (2002) Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8:240–246. doi:10.1038/nm0302-240
  PubMed CAS Google Scholar
• Pezzilli R, Billi P, Miniero R, Dig BB (1997) Serum interleukin-10 in human acute pancreatitis. Dis Sci 42:1469–1472. doi:10.1023/A:1018814710291
  CAS Google Scholar
• Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549–1555. doi:10.1084/jem.174.6.1549
  PubMed CAS Google Scholar
• Kwon OJ (1997) The role of nitric oxide in the immune response of tuberculosis Korean. Med Sci 12:481–487
  CAS Google Scholar
• Gougerot-Podicalo MA, Elbim C, Chollet-Martin S (1996) Modulation by pro- and anti-inflammatory cytokines of the oxidative burst of human neutrophils. Pathol Biol (Paris) 44:36–41
  CAS Google Scholar
• Dandona P, Mohanty P, Hamouda W, Aljada A, Kumbkarni Y, Garg R (1999) Effect of dexamethasone on reactive oxygen species generation by leukocytes and plasma interleukin-10 concentrations: a pharmacodynamic study. Clin Pharmacol Ther 66:58–65. doi:10.1016/S0009-9236(99)70054-8
  PubMed CAS Google Scholar
• Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA (1993) Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol (Baltimore, Md.: 1950) 151:5666–5674
  CAS Google Scholar
• Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA (1995) Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. J Immunol (Baltimore, Md.: 1950) 154:4793–4802
  CAS Google Scholar
• Gunnett CA, Heistad DD, Berg DJ, Faraci FM (2000) IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 279:H1555–H1562
  PubMed CAS Google Scholar
• Keel M, Ungethum U, Steckholzer E et al (1997) Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90:3356–3363
  PubMed CAS Google Scholar
• Adamopoulos S, Parissis JT, Paraskevaidis I et al (2003) Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 24:2186–2196. doi:10.1016/S0195-668X(03)00480-9
  PubMed CAS Google Scholar
• El Azab SR, Rosseel PM, de Lange JJ et al (2002) Dexamethasone decreases the pro- to anti inflammatory cytokine ratio during cardiac surgery. Br J Anaesth 88:496–501. doi:10.1093/bja/88.4.496
  PubMed CAS Google Scholar
• Giomarelli P, Scolletta S, Borrelli E, Biagioli B (2003) Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg 76:117–123. doi:10.1016/S0003-4975(03)00194-2
  PubMed Google Scholar
• Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM (1995) IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96:2304–2310. doi:10.1172/JCI118286
  PubMed CAS Google Scholar
• Ksontini R, MacKay SL, Moldawer LL (1998) Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation. Arch Surg 133:558–567. doi:10.1001/archsurg.133.5.558
  PubMed CAS Google Scholar
• Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S (1994) Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179:1695–1699. doi:10.1084/jem.179.5.1695
  PubMed CAS Google Scholar
• Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95:2868–2876. doi:10.1172/JCI117993
  PubMed CAS Google Scholar
• Wang P, Wu P, Anthes JC, Siegel MI, Egan RW, Billah MM (1994) Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83:2678–2683
  PubMed CAS Google Scholar
• Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205–1208. doi:10.1084/jem.177.4.1205
  PubMed CAS Google Scholar
• Gerard C, Bruyns C, Marchant A et al (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547–550. doi:10.1084/jem.177.2.547
  PubMed CAS Google Scholar
• Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272:50–53. doi:10.1126/science.272.5258.50
  PubMed CAS Google Scholar
• Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146. doi:10.1016/0167-5699(96)80606-2
  PubMed CAS Google Scholar
• Stumpf C, Lehner C, Yilmaz A, Daniel WG, Garlichs CD (2003) Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure. Clin Sci 105:45–50. doi:10.1042/CS20020359
  PubMed CAS Google Scholar
• Waehre T, Halvorsen B, Damas JK et al (2002) Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32:803–810. doi:10.1046/j.1365-2362.2002.01069.x
  PubMed CAS Google Scholar
• Lentsch AB, Shanley TP, Sarma V, Ward PA (1997) In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 15:2443–2448. doi:10.1172/JCI119786
  Google Scholar
• Shan K, Kurrelmeyer K, Seta Y et al (1997) The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 12:218–223. doi:10.1097/00001573-199705000-00002
  PubMed CAS Google Scholar
• Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol 274:R577–R595
  PubMed CAS Google Scholar
• Mann DL (1996) The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. J Card Fail 2:S165–S172. doi:10.1016/S1071-9164(96)80073-X
  PubMed CAS Google Scholar
• Kelly A, Lynch E, Vereker Y et al (2001) The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J Biol Chem 276:45564–45572. doi:10.1074/jbc.M108757200
  PubMed CAS Google Scholar